Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
University of Rochester
University of Rochester
Convalife (Shanghai) Co., Ltd.
Seagen Inc.
US Oncology Research
University of Miami
GlaxoSmithKline
Baylor Breast Care Center
University of Florida
UNICANCER
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center